FDA Inspection 1182041 — South Florida Institute For Reproductive Medicine, P.A.

South Florida Institute For Reproductive Medicine, P.A. — FEI 3003926766

The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on October 19, 2022 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 19, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
South Miami, FL (United States)